BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17016581)

  • 1. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.
    Chong IW; Chang MY; Chang HC; Yu YP; Sheu CC; Tsai JR; Hung JY; Chou SH; Tsai MS; Hwang JJ; Lin SR
    Oncol Rep; 2006 Nov; 16(5):981-8. PubMed ID: 17016581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblast migration in non-small cell lung cancers is modulated by increased integrin α11 expression.
    Iwai M; Tulafu M; Togo S; Kawaji H; Kadoya K; Namba Y; Jin J; Watanabe J; Okabe T; Hidayat M; Sumiyoshi I; Itoh M; Koyama Y; Ito Y; Orimo A; Takamochi K; Oh S; Suzuki K; Hayashizaki Y; Yoshida K; Takahashi K
    Mol Oncol; 2021 May; 15(5):1507-1527. PubMed ID: 33682233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
    Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
    Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.
    Ando T; Kage H; Matsumoto Y; Zokumasu K; Yotsumoto T; Maemura K; Amano Y; Watanabe K; Nakajima J; Nagase T; Takai D
    Cancer Sci; 2020 Jan; 111(1):200-208. PubMed ID: 31778288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
    Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
    Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens.
    Rizou T; Perlikos F; Lagiou M; Karaglani M; Nikolopoulos S; Toumpoulis I; Kroupis C
    J BUON; 2018; 23(6):1699-1710. PubMed ID: 30610797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of DNA repair enzyme hMTH1 mRNA and protein in hepatocellular carcinoma.
    Zhou H; Cheng B; Lin J
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):389-92. PubMed ID: 16196284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
    Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue.
    Kennedy CH; Pass HI; Mitchell JB
    Free Radic Biol Med; 2003 Jun; 34(11):1447-57. PubMed ID: 12757855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
    Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
    Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
    Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
    Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).
    Kotoula V; Krikelis D; Karavasilis V; Koletsa T; Eleftheraki AG; Televantou D; Christodoulou C; Dimoudis S; Korantzis I; Pectasides D; Syrigos KN; Kosmidis PA; Fountzilas G
    BMC Cancer; 2012 Aug; 12():342. PubMed ID: 22866924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.